Immuneering Corporation

Immuneering Corporation

Immuneering Corporation's Stock Takes a Hit Amidst Funding Round Despite Promising Clinical Data

Boston, MA – September 27, 2025 – Immuneering Corporation (NASDAQ: IMRX) experienced a significant downturn in its stock value on September 25, 2025, with shares declining by approximately 13.3%. This notable drop came on the heels of the company's announcement and pricing of a substantial public stock offering, a